Lactococcus lactisas a live vector for mucosal delivery of therapeutic proteins
نویسندگان
چکیده
منابع مشابه
Lactococcus lactis as a live delivery vector
Mucosal surfaces of the body provide a universal entry portal for all known and emerging infectious pathogenic microbes. Therefore, it seems that special vaccination strategies are needed for vaccines that can hinder the entry capability of pathogenic microbes through the mucosal surfaces. Lactic acid bacteria are widely used in the food industry and are presently applied as delivery vehicles i...
متن کاملlactococcus lactis as a live delivery vector
mucosal surfaces of the body provide a universal entry portal for all known and emerging infectious pathogenic microbes. therefore, it seems that special vaccination strategies are needed for vaccines that can hinder the entry capability of pathogenic microbes through the mucosal surfaces. lactic acid bacteria are widely used in the food industry and are presently applied as delivery vehicles i...
متن کاملLive Attenuated Shigella as a Diarrheal Vaccine And/or Mucosal Delivery Vector for Dna Vaccines
Several live attenuated Shigella vaccines of different serotypes have been shown to be safe, immunogenic, and in one case effective against challenge with virulent strains. The ability to invade epithelial cells remains critical for the success of these vaccine candidates. Live, orally administered Shigella vaccine derivatives are also being evaluated as multivalent mucosal vaccines able to del...
متن کاملVector Targeting for Therapeutic Gene Delivery
basis for exploring the macroevolutionary history of Earth and the origin of species. Finally, all these elements are nicely synthesized in a particularly readable chapter on human evolution and both our uniqueness from and our similarity to other species. A brief recap ofsome major areas of active research precedes two appendices, one of which adopts the "frequently asked questions" model to p...
متن کاملHuman scFv SIgA expressed on Lactococcus lactis as a vector for the treatment of mucosal disease.
The gastrointestinal tract is a complex niche and the main port of entry of many pathogens that trigger a wide range of diseases like inflammatory bowel disease (IBD) and colon cancer. Antibodies are effective for treating such diseases, but a system capable of local delivery at the site of the pathology, thus avoiding systemic side effects, is not yet available. Here we report a novel recombin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Vaccines
سال: 2009
ISSN: 1554-8600,1554-8619
DOI: 10.4161/hv.5.4.7553